支持在校人才培養，助力疾控體系改革，耀動中國公衛新未來

上海2022年11月(yue)6日(ri) /美(mei)通社/ -- 2022年第五屆中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)國(guo)(guo)(guo)(guo)(guo)際(ji)進口博(bo)覽(lan)會(hui)（以下(xia)簡稱"進博(bo)會(hui)"）期間，由默沙(sha)東(dong)(dong)（默沙(sha)東(dong)(dong)是(shi)美(mei)國(guo)(guo)(guo)(guo)(guo)新(xin)澤西州羅威市默克(ke)公(gong)司的(de)公(gong)司商號(hao)）及(ji)中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)疫苗(miao)行業協(xie)(xie)會(hui)發起的(de)"中(zhong)(zhong)苗(miao)協(xie)(xie)-默沙(sha)東(dong)(dong)菁衛公(gong)共(gong)衛生(sheng)(sheng)獎(jiang)助學(xue)金項目"在(zai)默沙(sha)東(dong)(dong)展(zhan)臺正式(shi)啟(qi)動。中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)疫苗(miao)行業協(xie)(xie)會(hui)會(hui)長封(feng)多佳、中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)醫科大(da)學(xue)公(gong)共(gong)衛生(sheng)(sheng)學(xue)院黨(dang)委書記兼副院長王溪原、中(zhong)(zhong)山大(da)學(xue)公(gong)共(gong)衛生(sheng)(sheng)學(xue)院院長夏敏(min)、以及(ji)默沙(sha)東(dong)(dong)全球高級副總裁兼默沙(sha)東(dong)(dong)中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)總裁田(tian)安娜（Anna Van Acker）攜手展(zhan)望(wang)未(wei)來"公(gong)衛山河"，表達各方同心聚(ju)力(li)(li)支持(chi)公(gong)共(gong)衛生(sheng)(sheng)領域在(zai)校人才培養、增強公(gong)衛人才儲備、助力(li)(li)疾(ji)控體系(xi)改革(ge)、共(gong)筑"健(jian)康中(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)"的(de)使命(ming)愿景(jing)。

作為(wei)"十四五(wu)"規(gui)劃"以人(ren)民健(jian)康(kang)為(wei)中(zhong)(zhong)(zhong)心"的政策(ce)縮影，以及建(jian)設"健(jian)康(kang)中(zhong)(zhong)(zhong)國"的前沿陣(zhen)地，公(gong)(gong)衛(wei)系(xi)統承(cheng)擔著抗擊傳(chuan)染性(xing)疾(ji)病(bing)、守護(hu)公(gong)(gong)眾(zhong)健(jian)康(kang)的重(zhong)任。而公(gong)(gong)衛(wei)人(ren)才隊伍的質(zhi)量與疾(ji)病(bing)防(fang)控進程密切相關，公(gong)(gong)衛(wei)教育水平(ping)提升和(he)(he)人(ren)才隊伍建(jian)設便顯得(de)尤為(wei)重(zhong)要。伴隨生(sheng)命科學與醫(yi)療創新(xin)(xin)的加(jia)速(su)發展，中(zhong)(zhong)(zhong)國公(gong)(gong)衛(wei)教育和(he)(he)人(ren)才培養取得(de)了(le)長足(zu)進步，但(dan)面對新(xin)(xin)冠肺炎疫情持續蔓延(yan)、以及多種(zhong)傳(chuan)染性(xing)疾(ji)病(bing)集(ji)中(zhong)(zhong)(zhong)爆(bao)發的挑戰(zhan)，中(zhong)(zhong)(zhong)國仍(reng)亟(ji)需更(geng)多、更(geng)好的復合型、應用型、創新(xin)(xin)型人(ren)才，推動公(gong)(gong)衛(wei)體(ti)系(xi)向高質(zhi)量、有活力、可持續的目(mu)標邁進。

中國疫苗行業協會會長封多佳介紹(shao)道，菁衛(wei)(wei)(wei)公(gong)(gong)(gong)(gong)(gong)(gong)共衛(wei)(wei)(wei)生(sheng)(sheng)(sheng)獎(jiang)(jiang)助(zhu)學(xue)(xue)(xue)金項(xiang)目計(ji)劃對全國重點高校公(gong)(gong)(gong)(gong)(gong)(gong)共衛(wei)(wei)(wei)生(sheng)(sheng)(sheng)學(xue)(xue)(xue)院的(de)學(xue)(xue)(xue)生(sheng)(sheng)(sheng)進行獎(jiang)(jiang)助(zhu)學(xue)(xue)(xue)金的(de)資(zi)(zi)助(zhu)，首批資(zi)(zi)助(zhu)高校包括中國醫科大學(xue)(xue)(xue)公(gong)(gong)(gong)(gong)(gong)(gong)共衛(wei)(wei)(wei)生(sheng)(sheng)(sheng)學(xue)(xue)(xue)院和中山大學(xue)(xue)(xue)公(gong)(gong)(gong)(gong)(gong)(gong)共衛(wei)(wei)(wei)生(sheng)(sheng)(sheng)學(xue)(xue)(xue)院。項(xiang)目旨在(zai)為青(qing)年人才(cai)專(zhuan)心向學(xue)(xue)(xue)排憂解難，鼓勵(li)公(gong)(gong)(gong)(gong)(gong)(gong)衛(wei)(wei)(wei)學(xue)(xue)(xue)子(zi)以昂揚熱情(qing)投身"建設(she)(she)強大公(gong)(gong)(gong)(gong)(gong)(gong)共衛(wei)(wei)(wei)生(sheng)(sheng)(sheng)體系"的(de)國家戰略大業；為公(gong)(gong)(gong)(gong)(gong)(gong)衛(wei)(wei)(wei)事(shi)業儲(chu)備(bei)新型(xing)后備(bei)軍(jun)，助(zhu)力提升公(gong)(gong)(gong)(gong)(gong)(gong)衛(wei)(wei)(wei)科研(yan)和實踐的(de)整體水平(ping)；激活(huo)產(chan)學(xue)(xue)(xue)研(yan)的(de)協(xie)同(tong)效應，強化各級疾病防控機構的(de)能力建設(she)(she)，提升全民(min)健康(kang)管理水平(ping)。

中國醫科大學公共衛生學院黨委書記兼副院長王溪原指出(chu)，公(gong)(gong)(gong)衛(wei)人(ren)(ren)才(cai)是(shi)保障人(ren)(ren)民群眾(zhong)健康的(de)"守門人(ren)(ren)"。此(ci)次(ci)新(xin)冠疫(yi)情對公(gong)(gong)(gong)衛(wei)體系和隊伍建(jian)設提出(chu)了新(xin)要求，同(tong)時也為相關(guan)學科的(de)建(jian)設發展(zhan)和人(ren)(ren)才(cai)培養(yang)帶來了新(xin)機遇。新(xin)型公(gong)(gong)(gong)衛(wei)人(ren)(ren)才(cai)除了擁有(you)扎實的(de)基本(ben)理論(lun)知識和數據(ju)分(fen)析能(neng)力(li)(li)，還(huan)需(xu)具備敏銳的(de)大局(ju)意識、過硬的(de)實操技能(neng)、全(quan)面(mian)的(de)應急處理能(neng)力(li)(li)等。而這(zhe)樣綜合性高(gao)素質公(gong)(gong)(gong)衛(wei)人(ren)(ren)才(cai)的(de)培養(yang)并非一蹴而就，高(gao)校加大投入的(de)同(tong)時，還(huan)需(xu)全(quan)社會通力(li)(li)合作。菁(jing)衛(wei)公(gong)(gong)(gong)共衛(wei)生獎助(zhu)學金項(xiang)目正是(shi)拓展(zhan)人(ren)(ren)才(cai)培養(yang)和職(zhi)業發展(zhan)路徑，優(you)化公(gong)(gong)(gong)衛(wei)人(ren)(ren)才(cai)發展(zhan)系統，完善公(gong)(gong)(gong)衛(wei)疾控體系的(de)有(you)益(yi)探(tan)索。

"在新冠肺炎疫情大背景下，伴隨公衛范疇與內容在深度和廣度上的不斷延展，不斷完善公衛體系已成為構建人類衛生健康共同體的核心抓手。"中山大學公共衛生學院院長夏敏表(biao)示，我們(men)希望通(tong)過菁衛(wei)(wei)公共衛(wei)(wei)生獎助學金項目(mu)，培養高素質人才、提升專業人才比例、壯(zhuang)大(da)人才隊(dui)伍，推動(dong)公衛(wei)(wei)教育‘更上一層樓'，也期待公衛(wei)(wei)學子(zi)志(zhi)存高遠、篤志(zhi)好(hao)學，踴躍投身公衛(wei)(wei)學術研究和實踐探索，助力中(zhong)國公衛(wei)(wei)事業的跨越式(shi)發(fa)展，為保(bao)障(zhang)人民生命安全貢獻力量。

默沙東全球高級副總裁兼默沙東中國總裁田安娜表示(shi)，"建設(she)強(qiang)大(da)(da)的(de)公(gong)(gong)共(gong)衛生體(ti)系需要多方協(xie)力(li)，而人才(cai)是體(ti)系建設(she)的(de)基石。默(mo)沙(sha)東非常(chang)榮幸能與中國(guo)疫苗行業(ye)協(xie)會聯合發(fa)起菁衛公(gong)(gong)共(gong)衛生獎助學金項目，支持高等院校(xiao)為社會輸送更多公(gong)(gong)衛人才(cai)，壯大(da)(da)中國(guo)公(gong)(gong)衛青年精英隊伍，為醫療健康行業(ye)發(fa)展(zhan)注入(ru)源源動(dong)力(li)。"

進入中國30年來，默沙東憑借豐富的疫苗產品和抗感染藥物等管線，從預防到治療，為女性、兒童及青少年、老年人等不同群體提供覆蓋全生命周期的健康保護。田安娜強調，"站在三十而‘力(li)(li)'的新(xin)起點，默沙東將以‘耀動未來'戰略為指引，凝聚社會各界力(li)(li)量，不斷將更多能夠挽(wan)救(jiu)生(sheng)(sheng)命的先進疫苗、藥物(wu)、疾病防(fang)控項(xiang)目和體系模式帶到中國(guo)(guo)，成為中國(guo)(guo)醫療生(sheng)(sheng)態系統中值得信(xin)賴(lai)和領(ling)先的合作伙伴；支持中國(guo)(guo)疾病防(fang)控改革(ge)和公衛事業發展，以‘增(zeng)輝生(sheng)(sheng)命'的堅定信(xin)念(nian)，默守(shou)‘健康中國(guo)(guo)'的山河新(xin)綠(lv)。"

若您想了(le)解更多有關疾(ji)病知識的信息，請咨(zi)詢(xun)醫療衛生專業人士11-2022-CN-HPV-00728